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Abstract Repeated episodes of ischemia followed by
reperfusion, commonly referred to as ischemic precondi-
tioning (IPC), represent an endogenous protective mecha-
nism that delays cell injury. IPC also increases blood Xow
and improves endothelial function. We hypothesize that
IPC will improve physical exercise performance and maxi-
mal oxygen consumption. The purpose of the study was to
examine the eVect of ischemic preconditioning in leg skele-
tal muscles on cycling exercise performance in healthy
individuals. Fifteen healthy, well-trained subjects per-
formed two incremental maximal exercise tests on a bicycle
ergometer. Power output, oxygen consumption, ventilation,
respiratory quotient, and heart rate were measured continu-
ously. Blood pressure and blood lactate were measured
before and after the test. One exercise test was performed
after the application of ischemic preconditioning, using a
protocol of three series of 5-min ischemia at both legs with
resting periods of 5 min in between. The other maximal
cycling test served as a control. Tests were conducted in
counterbalanced order, at least 1 week apart, at the same
time of the day. The repeated ischemic periods signiWcantly
increased maximal oxygen consumption from 56.8 to
58.4 ml/min per kg (P = 0.003). Maximal power output
increased signiWcantly from 366 to 372 W (P =0 . 0 5 ) .
Ischemic preconditioning had no eVect on ventilation,
respiratory quotient, maximal heart rate, blood pressure or
on blood lactate. Repeated short-term leg ischemia prior to
an incremental bicycle exercise test improves maximal
oxygen consumption by 3% and power output by 1.6%.
This protocol, which is suggested to mimic the eVects of
ischemic preconditioning, may have important implications
for exercise performance.
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Introduction
It has been demonstrated that brief, repeated periods of ische-
mia followed by reperfusion, commonly referred as “ische-
mic preconditioning” (IPC), causes a delay of lethal cell
injury in (cardiac) muscles as well as in organs (Eisen et al.
2004; Murry et al. 1986; Reimer et al. 1986). Although the
underlying mechanism(s) are not uniformly understood, the
beneWcial eVects of IPC for cardiac and skeletal muscle cells
to prevent ischemic damage are generally accepted.
From the available evidence, adenosine and ATP-sensi-
tive potassium (KATP) channels are identiWed to play, at
least partly, a role in the eVects of IPC. Administration of
an adenosine-blocker (Hopper et al. 2000; Schroeder et al.
1996) or KATP-antagonist (Gross and Auchampach 1992;
Hopper et al. 2000; Pang et al. 1997) attenuates the protec-
tive eVects of IPC, while the protective eVects are enhanced
when agonists are administrated. An important conse-
quence of elevated adenosine levels and ATP-sensitive
potassium (KATP) channels is an enhanced vasodilation.
Interestingly, adenosine levels and ATP-sensitive potassium
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(KATP) channels are also involved in matching the delivery
of oxygen and substrates to the increased metabolic
demand of muscles during exercise.
In addition to the eVects of IPC on the vasculature, stud-
ies have found that IPC improves muscle function (Lawson
and Downey 1993) and metabolism (Pang et al. 1995).
Based on the eVects of IPC on vessels and muscles, IPC
prior to an exercise bout is hypothesized to improve physi-
cal exercise performance and maximal oxygen consump-
tion in healthy subjects. Therefore, the aim of the present
study is to examine the eVect of IPC in leg muscles on oxy-
gen consumption and workload during a maximal cycling
test in healthy subjects.
Methods
Subjects
Fifteen healthy individuals (twelve males and three
females, age 27 § 6 years) volunteered to participate in this
study. All subjects were well-trained cyclists and were non-
smokers. Based on their medical history, subjects did not
have any medical problems and were free of any medica-
tion. Subject characteristics are summarized in Table 1.
Prior to participation, all subjects gave their written
informed consent. The ethics committee of the Radboud
University Nijmegen Medical Centre approved the study.
Protocol and measurements
All subjects refrained from alcohol, caVeine, and intensive
physical exercise for at least 24 h prior to testing. All tests
were performed in laboratory conditions with constant tem-
perature (20°C) and humidity (35%).
Each subject reported to the laboratory twice and per-
formed an incremental maximal exercise test on a cycling
ergometer (Lode, Excalibur, Groningen, the Netherlands) at
both days. The experiments were performed at least 1 week
apart and at the same time of the day. Subjects were not
informed about the rationale of the study, to prevent a pla-
cebo eVect of IPC. One test was performed in combination
with IPC. In order to banish possible confounding training
or familiarization eVects, the application of IPC was
assigned in counterbalanced order. Seven subjects started
the  Wrst maximal test without IPC, while eight subjects
started the Wrst maximal test preceded by IPC.
The incremental maximal cycling test started at a power
output of 50 W for 4 min, followed by 4 min at 100 W and
4 min at 150 W. After this, the power output increased
by 20 W/min until exhaustion (Fig. 1). Subjects were
instructed to keep cadence between 60 and 80 rpm.
Starting 2 min prior to and throughout the maximal
exercise test, oxygen consumption (VO2, in ml O2/kg per
min), ventilation (Ve, in l/min), respiratory quotient
(RQ) (Oxycon IV, Jaeger, Germany), and heart rate (HR,
in bpm) (Cardiotest EK 41, Depex, the Netherlands)
were measured and recorded continuously. Manually,
brachial artery blood pressure was measured before and
immediately after each maximal exercise test. Blood lac-
tate (mmol/l) was measured using Accutrend® Lactate
(Roche Diagnostics GmbH, type 3012522, Mannheim,
Germany) before and 2 min after Wnishing the maximal
exercise test.
Table 1 Baseline subject characteristics (n =1 5 )
Values are expressed as mean § SD
Baseline characteristics Mean § SD
Age (years) 27.2 § 5.6
Weight (kg) 73.2 § 10.1
Height (cm) 181 § 9
Sport time (h/week) 7.8 § 3.9
Systolic blood pressure (mmHg) 128 § 14
Diastolic blood pressure (mmHg) 79 § 13
Fig. 1 Protocol of the study. 
IPC ischemic preconditioning, 
VO2max test incremental bicycle 
exercise test with measurement 
of maximal oxygen consump-
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Gray square boxes represent 
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Ischemic preconditioning
Ischemic preconditioning (IPC) was performed in supine
position using bilateral arterial occlusion. The occlusion
cuVs were positioned proximally around the thigh and inX-
ated to 220 mmHg for 5 min. This procedure allows a com-
plete blockade of the arterial inXow in the lower limbs
throughout these 5 min (Kooijman et al. 2008). This ische-
mic procedure was repeated three times, each separated by
5 min of reperfusion (Bushell et al. 2002). In animal stud-
ies, this IPC protocol was found to be optimal to protect rat
muscles from ischemia-induced damage (Bushell et al.
2002). Five minutes after the IPC, the maximal exercise test
started (Fig. 1).
Data analysis
Oxygen consumption, ventilation, and respiratory quotient
were averaged over intervals of 30 s. Resting values were
averaged over a 2-min period. The maximal values were
represented as the mean of the last minute in which exercise
was performed. In addition, oxygen consumption, ventila-
tion, and respiratory quotient were analyzed during the
4-min steady state submaximal levels at 50, 100, and
150 W using the mean of the last 2 min in these periods.
Statistics
Data is presented as mean § SD, unless stated otherwise.
Shapiro–Wilk and Kolmogorov–Smirnov tests indicated a
normal (Gaussian) distribution of data. Therefore, a two-
tailed paired Student’s t test was used to assess diVerences
in oxygen consumption, power output, ventilation, respira-
tory quotient, maximal heart rate, blood pressure, and lactate
concentration between the baseline and the IPC-maximal
exercise test. DiVerences were considered to be statistically
signiWcant at P · 0.05.
Results
Baseline
Baseline characteristics were similar between both testing
days (Table 1).
Maximal performance
Maximal oxygen consumption was signiWcantly higher
with IPC 58.4 ml/min per kg than without 56.8 ml/min per
kg (t test: P =0 . 0 0 3 ;  F i g .2). Maximal power output
reached higher values with IPC 372 W compared to without
366 W (P = 0.05). Ventilation, respiratory quotient, maximal
heart rate, post-exercise blood pressure, and blood lactate
concentrations were not diVerent between both maximal
cycling tests (with and without IPC) (Table 2).
Submaximal performance
At the submaximal levels of 50, 100, and 150 W, we con-
Wrmed the presence of a steady state, indicated by no fur-
ther increase in oxygen consumption (·150 ml O2/kg per
min) during the last 2 min of each stage. Oxygen consump-
tion, heart rate, ventilation, and respiratory quotient were
not diVerent between the IPC and non-IPC steady state
levels of the cycling test (Table 2).
Fig. 2 Individual and mean maximal oxygen consumption (VO2max
in ml/min per kg) during the maximal exercise test without (black
square) and with ischemic preconditioning (IPC, open square).
N = 15. Error bars represent SE. *P <0 . 0 0 3
Table 2 Maximal oxygen consumption (VO2max), maximal power
output, ventilation, respiratory quotient, maximal heart rate (HRmax),
and blood pressure before the test started (BPrest) and immediately
after Wnishing exercise (BPmax) presented as systolic/diastolic blood
pressure (syst/diast), blood lactate, and oxygen consumption (VO2) at
50, 100, and 150 W for the test without ischemic preconditioning
(control) and the test preceded by ischemic preconditioning (IPC) in
healthy young participants (n =1 5 )
Values are expressed as mean (SD)
Control IPC P value
VO2max (ml/min per kg) 56.8 (6.8) 58.4 (6.2) 0.003
Maximal power output (W) 366 (62) 372 (59) 0.05
Ventilation (l/min) 143.4 (29.7) 148.9 (22.6) NS
Respiratory Quotient 1.20 (0.1) 1.20 (0.1) NS
HRmax (bpm) 183 (9) 183 (7) NS
BPrest syst/diast (mmHg) 130/83 129/83 NS
BPmax syst/diast (mmHg) 177/66 173/68 NS
Lactate (mmol/l) 12.3 (3.6) 13.3 (3.5) NS
VO2 at 50 W (ml/min per kg) 15.4 (1.6) 15.6 (1.4) NS
VO2 at 100 W (ml/min per kg) 21.8 (2.0) 21.9 (2.2) NS
VO2 at 150 W (ml/min per kg) 29.1 (3.0) 29.2 (3.2) NS144 Eur J Appl Physiol (2010) 108:141–146
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Discussion
The major Wnding of the present study is that ischemic pre-
conditioning of the legs in healthy subjects signiWcantly
increased maximal oxygen consumption by 3% and power
output by 1.6% during maximal cycling performance. At
submaximal exercise levels, IPC has no eVect on any of the
physiological variables. Although the underlying mecha-
nism for this IPC-induced improvement in exercise perfor-
mance needs to be elucidated, it may have profound
consequences for exercise performance in athletes.
Unique in this study is the application of IPC to examine
its eVects on performance of the maximal cycling test in
humans. The non-invasive nature and easy applicability of
IPC are the important advantages. The descriptive nature of
our study-design limits identiWcation of the underlying
mechanisms of the beneWcial eVects of the IPC on cycling
performance. Since the eVects of repeated short-term ische-
mia on muscle performance have never been examined
before, the primary aim of the present study was to assess
this eVect and not to elucidate the underlying mechanisms.
The 3% increase of maximal oxygen consumption after
ischemic preconditioning in our trained subjects is compa-
rable with the improvement in maximal oxygen consump-
tion after »1 month altitude training. Previous studies in
well-trained (Levine and Stray-Gundersen 1997) or elite
runners (Stray-Gundersen et al. 2001) demonstrated an
increase in maximal oxygen consumption by 5 and 3%,
respectively, when a 4-week ‘living high-training low’ pro-
tocol was performed. In the present study we showed that a
»20-min session of IPC prior to an exercise test has similar
improvements in maximal oxygen consumption compared
with a well-established method for elite athletes to improve
their performance. The 3% increase in oxygen consumption
was in consonance with a signiWcant and meaningful
increase in maximal power output during the exercise test.
Such improvement in maximal performance level is highly
relevant in sports competition, since we know that during
competitive events the diVerence between silver and gold
can be minimal. As such, our results may have major impli-
cations for exercise performances at competitive levels.
This is the Wrst human study that provides evidence that
IPC beneWcially alters performance level in humans. Given
the explorative character of our study, we can only specu-
late about the possible mechanisms underlying the immedi-
ate improvement in cycling performance. Delivery of
nutrients and oxygen to the peripheral tissues by blood is a
potential limiting factor during exercise. Interestingly, pre-
vious studies suggested a positive impact of IPC on the vas-
culature, which may underlie the eVects of IPC on exercise
performance. The vasodilation response after exposure of
rat muscles to IPC can be blocked using ATP-sensitive
potassium channels (KATP) blockers (Weselcouch et al.
1993), which suggests that activation of KATP channels con-
tributes to the eVect of IPC on the vasculature. Interest-
ingly, activation of KATP channels also initiates functional
sympatholysis in humans during exercise (Keller et al.
2004), an important integrative response during exercise to
optimally meet the increased metabolic requirements
through redistributing blood from inactive to active regions.
In addition, another mechanism that relates to IPC-induced
changes in the vasculature is adenosine, which is a potent
vasodilator that contributes to the vasodilation response
during exercise (Joyner and Proctor 1999). Therefore,
adenosine may help to optimize the blood supply during
exercise. Findings from studies that have blocked adeno-
sine during IPC, support the idea that the protective eVects
of adenosine during IPC are mediated via adenosine recep-
tor subtype A1 and A2B activation, expressed on cardiomyo-
cytes and vascular endothelial cells (Rubio et al. 1999;
Todd et al. 1996).
Although the changes in adenosine and KATP channels
may enhance maximal exercise-induced blood Xow, this
does not necessarily improve oxygen consumption, as O2
extraction can be decreased due to a less eYcient Xow dis-
tribution (Calbet et al. 2006). Interestingly, a previous
study found a signiWcant increase in muscle oxygenation
during exhaustive exercise in rats treated with IPC com-
pared to exercise in rats without IPC (Saito et al. 2004).
They indicated that these diVerences cannot be explained
by morphological diVerences, but rather relate to acute
functional changes. Although studies should further exam-
ine these mechanisms, IPC-induced vascular adaptations
may contribute to the higher oxygen uptake and elevated
exercise performance found in our study.
In addition to IPC-induced changes in the vasculature,
the improved performance level after IPC may also relate to
adaptations in muscles, or more speciWcally in the mito-
chondria. To date, only two studies examined the eVect of
IPC on muscular performance in animals. One study found
an improved force and contractility, as well as decreased
fatigue in rat skeletal muscles after IPC (Lawson and
Downey 1993). In addition, Pang et al. showed that IPC
might protect pig skeletal muscles by promoting ATP-spar-
ing during the subsequent ischemic event. It was speculated
that ATP-sparing may have occurred through a tightening
of excitation–contraction coupling, a reduction in futile ion
pumping, and/or through a relatively lower reliance on
anaerobic energy production without compromising force
generation (Pang et al. 1995). If ATP-sparing occurred in
our study, one may expect to Wnd a more eYcient muscle,
leading to a larger work per oxygen consumed. However,
power output at submaximal level was similar between
both exercise bouts, while the increase in power output was
comparable to the change in oxygen consumption at maxi-
mal cycling.Eur J Appl Physiol (2010) 108:141–146 145
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Moreover, a recent study found that IPC is able to
improve nitric oxide (NO) availability in young healthy
adults (Kimura et al. 2007). In addition to potential vasodi-
lator eVects, it may also favorably impact upon the ability
to consume oxygen during exercise, as NO has been shown
to attenuate mitochondrial oxygen consumption through
maintenance of an O2 extraction reserve (Cooper and
Brown 2008; Prime et al. 2009).
Limitations Because the subjects were not blinded for the
IPC intervention, one may argue that this might have inXu-
enced our results. However, subjects were blinded for the
power output level and the time of performance during the
test. In addition, participants were naïve and were not
informed about the potential eVect of IPC on exercise per-
formance. Moreover, heart rate, respiratory quotient, and
lactate levels were similar between both tests. These param-
eters indicate that during both exercise bouts, subjects per-
formed a maximal performance that was not diVerent
between both days. Therefore, our study design had no
impact on the major outcomes of our study. Another limita-
tion relates to the fact that subjects started their exercise
bout within 5 min after completing the IPC protocol. As a
result, we examined the immediate impact of IPC and can-
not extend our observations to a longer time-window
between IPC and the start of exercise. As such, little is
known about the optimal IPC protocol and timing to
improve exercise performance.
In conclusion, an ischemic preconditioning protocol of
three series of 5-min arterial occlusion of the legs in healthy
subjects increases maximal oxygen consumption by 3%
and power output by 1.6% during an incremental bicycle
exercise test. We strongly support future studies to examine
the potential impact of (diVerent procedures of) IPC for
exercise performance at competitive levels.
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